X4 Pharmaceuticals, Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
X4 Pharmaceuticals, Inc has filed 796 SEC EDGAR filings since 24 Sep 2010

SEC filing history

Showing 151-175 of 796 matching filings.

Per page
25
Current page
7
4

FORM 4

Filing date
11 Jun 2024
Reporting date
10 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2024
Reporting date
10 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2024
Reporting date
10 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2024
Reporting date
10 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2024
Reporting date
10 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2024
Reporting date
10 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2024
Reporting date
10 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-38295

ARS

Filing date
29 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38295

DEFA14A

Filing date
29 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38295

DEF 14A

Filing date
29 Apr 2024
Reporting date
29 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Mar 2024
Reporting date
11 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Mar 2024
Reporting date
11 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Mar 2024
Reporting date
11 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Mar 2024
Reporting date
11 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38295

144 filing

Filing date
11 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .